+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Fletcher's Diagnostic Histopathology of Tumors, 2 Volume Set. Edition No. 6

  • Book

  • December 2026
  • Elsevier Health Science
  • ID: 6252833
Authoritative, clearly written, and easy to navigate, Fletcher's Diagnostic Histopathology of Tumors, 6th Edition, remains your go-to resource for accurate, efficient evaluation and interpretation of histopathology specimens. Continuing the tradition of excellence established by Dr. Christopher Fletcher, Dr. Jason L. Hornick leads a team of internationally renowned experts in tumor pathology to provide superbly illustrated information on pathogenesis, diagnostic criteria, molecular/cytogenetic findings, and prognosis on the neoplastic diseases most likely to be encountered by general surgical pathologists, helping you stay current with the latest diagnostic tumor markers to assist in daily sign-out.
  • Uniquely prioritizes conventional histologic assessment, supported-but not replaced-by immunohistochemistry and molecular diagnostics
  • Features a practical, morphology-first approach while fully incorporating the latest TNM staging, WHO classifications, and emerging molecular insights, ensuring relevance across both high resource and resource-limited practice environments
  • Covers new diagnostic biomarkers, newly described variants, and new histologic entities
  • Offers expanded discussions of molecular diagnostic testing, including capabilities, limitations, and relevance to personalized medicine
  • Contains diagnostic flow charts, correlations of gross appearances to microscopic findings, and differential diagnosis tables for better recognition and evaluation of similar-looking entities
  • An eBook version is included with purchase. The eBook allows you to access all of the text, figures, and references, with the ability to search, make notes and highlights, and have content read aloud. Additional digital ancillary content may publish up to 6 weeks following the publication date

Authors

Jason L. Hornick Director of Surgical Pathology and Immunohistochemistry, Brigham and Women's Hospital, USA. Dr Hornick's major research interests are soft tissue sarcomas, gastrointestinal stromal tumor (GIST), gastrointestinal cancers, and mastocytosis. My focus in soft tissue sarcomas includes evaluating histologic and immunohistochemical parameters that predict clinical outcome and identifying diagnostic and predictive biomarkers. He serves on 12 editorial boards and was nominated for his prolific research on soft tissue pathology, having published around 400 original papers, review articles, and book chapters